Peritoneal dissemination is the most common mode of metastasis in gastric cancer. We previously reported the importance of milky spots (MS), peritoneal lymphoid tissues, as selective sites of cancer implantation in peritoneal dissemination. In the present study, we first demonstrated that intraperitoneal injection of adenovirus vector encoding the GFP gene into tumor-free nude mice resulted in GFP expression at omental and mesenteric MS; MS macrophages were target cells for adenovirus infection. We confirmed that intraperitoneal injection of adenovirus vector encoding the NK4 gene (AdNK4) resulted in NK4 production localized to the peritoneal cavity, especially the omentum. Adenovirus vector-mediated MS-selective transgene expression was markedly impaired in tumorbearing mice whose MS had already been replaced by infiltrating cancer cells. However, prior injection of AdNK4 successfully inhibited MS-selective cancer cell implantation, resulting in suppression of peritoneal dissemination and prolongation of survival. Adenovirus vector-mediated MS-selective delivery of a therapeutic gene may prevent peritoneal dissemination of gastric cancer.
P eritoneal dissemination is the most common mode of metastasis in advanced gastric cancer, and peritoneal recurrence develops in approximately half of the patients who receive radical, potentially curative resection of advanced gastric cancer with extended lymphadenectomy. [1] [2] [3] Once gross peritoneal dissemination appears along with intestinal obstruction or malignant ascites, present treatments are extremely limited. 4 Thus, preventing postoperative peritoneal recurrence is crucial for improving prognosis in patients with gastric cancer.
Milky spots (MS) are peritoneal lymphoid tissues composed of numerous macrophages and lymphocytes aggregates, and play an important role in a host defense system in the peritoneal cavity as the site of origin of free peritoneal macrophages. 5, 6 MS are involved in peritoneal dissemination of cancer as sites of implantation. [7] [8] [9] [10] We previously demonstrated in a mouse model that intraperitoneally (i.p.) injected cancer cells showed selective implantation to MS in the peritoneum; a significant correlation was found between the number of cancer cells infiltrating peritoneal locations such as omentum, mesentery, and gonadal fat (pelvic floor) and the number of MS at those locations. 9 Clinically, we demonstrated that i.p. injection of mitomycin C adsorbed onto activated carbon particles showed selective accumulation to MS, and sustained release of the drug was efficacious in the prevention of postoperative peritoneal recurrence of gastric cancer. 11 These findings strongly suggest that selective delivery of anticancer agents to MS may be an effective method to suppress peritoneal dissemination of gastric cancer. However, the use of anticancer drugs bound to activated carbon particles is restricted because of severe complications. cells; 16, 17 HGF affects the morphology of mesothelial cells such that they become prone to peritoneal dissemination of cancer cells. 18 NK4 is composed of the N-terminal hairpin and subsequent four kringle domains of HGF. NK4 not only acts as a competitive antagonist for HGF 19, 20 but also acts as a potent angiogenesis inhibitor independently. 21 Recent studies in a mouse model have demonstrated that NK4 exerts potent antitumor effects via these two actions in pancreatic cancer, [21] [22] [23] [24] [25] ovarian cancer, 26 lung cancer, 27 and gastric cancer. 28, 29 There are no studies regarding the efficacy of NK4 in the treatment of peritoneal dissemination of gastric cancer, although NK4 is reported to be effective in suppressing peritoneal dissemination of pancreatic [22] [23] [24] and ovarian cancer. 26 Adenovirus (Ad) vector is frequently used for gene therapy in cancer because of its high expression efficiency. 30 I.p. injection of Ad vector is reported to be efficacious for therapeutic gene delivery for mice with peritoneal dissemination. 24, 31 Biodistribution of transgene expression by i.p. injection of Ad vector is not fully understood, although selective transgene expression is elicited in the liver by intravenous injection of Ad vector. [32] [33] [34] [35] We investigated the biodistribution of transgene expression after i.p. injection of Ad vector in tumor-free and tumor-bearing mice, with special reference to possible relations with MS, using Ad vector encoding GFP (AdGFP) or NK4 genes (AdNK4), and we investigated whether i.p. injection of AdNK4 could suppress peritoneal dissemination of gastric cancer.
Results

In vitro HGF reactivity of cancer cells
We investigated the effects of HGF on in vitro proliferation and motility of MKN45 cells (Fig 1) . Proliferation was similar between MKN45 cells infected with AdLacZ (MKN45-AdLacZ) and those infected with AdNK4 (MKN45-AdNK4). NK4 production from MKN45-AdLacZ and MKN45-AdNK4 was o0.1 and 6.12 ng/ ml/48 hours, respectively. Expression levels of c-Met were similar between MKN45-AdLacZ and MKN45-AdNK4 Figure 1 Effect of HGF on in vitro proliferation and motility of cancer cells. For cell proliferation, MKN45-AdNK4 or MKN45-AdLacZ were plated at 2.5 Â 10 3 cells/well onto 24-well plates and cultured in RPMI 1640 with 10% FBS for 24 hours. The culture media were replaced with fresh RPMI 1640 with 5% FBS and the cells were cultured in the absence or presence of 10 ng/ml HGF. After 5 days, the cell number was counted (a). Invasion and migration of MKN45 cells were measured using a 24-well Matrigel invasion chamber and a Transwell chamber equipped with a filter membrane with 8 mm pores. The cells suspended in RPMI 1640 with 2% FBS were added to the inner cup of the chamber at a density of 10 5 cells/well. HGF (10 ng/ml) was added to the medium of the outer cup. After 24 hours of culture, cells that invaded or migrated to the opposite side of the membrane were counted. (b) and (c) show the results of migration and invasion assays, respectively. Each value represents the mean7SE (**Po.01).
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as detected by Western blot analysis (data not shown). Proliferation of MKN45-AdLacZ was slightly, but not significantly, enhanced by HGF stimulation, whereas that of MKN45-AdNK4 was not enhanced. In a motility assay, invasion and migration were enhanced by HGF stimulation in MKN45-AdLacZ, whereas they were not enhanced in MKN45-AdNK4. These results indicate that MKN45 cells have a functional c-Met receptor and their motility is stimulated by an HGF/c-Met-dependent pathway; adenovirus-mediated NK4 production in the cells inhibits the motility enhanced by HGF stimulation.
Evaluation of MS-selective implantation of cancer cells by GFP imaging
To investigate the behavior of peritoneal free cancer cells, we employed GFP imaging. Figure 2 shows omental and mesenteric MS 24 hours after i.p. injection of GFPexpressing MKN45 cells (MKN45-GFP). GFP expression under fluorescent microscopy was observed at sites identical to MS that were recognized as black-stained spots under light microscopy; expression was not detected at other sites, indicating that MKN45 cells by i.p. injection selectively accumulate to MS in peritoneal tissues. Green fluorescence was detected at MS promptly after injection and was not detected in the free peritoneal cavity at 24 hours after injection, indicating that most cells were absorbed from the free peritoneal cavity into the peritoneum, and then to MS by 24 hours after injection. In this model, MKN45 cells injected i.p. induced peritoneal carcinomatosis with macroscopic findings of disseminated tumor nodules and ascites in all of the mice.
Biodistribution of transgene expression by i.p. injection of Ad vector
We analyzed transgene expression in the peritoneal cavity by fluorescent microscopy on days 2, 5, and 7 after i.p. injection of AdGFP (10 9 PFU, twice) into tumor-free mice (Fig 3) . Green fluorescence was detected at blackstained MS in the omentum and mesentery, but not in peritoneal tissues or organs other than MS. Expression reached a peak on day 2 and disappeared by day 7 (data not shown). Thus, Ad particles were selectively accumulating to MS promptly after injection. To identify the cells responsible for Ad vector-mediated transgene expression at MS, we dissociated cells from the omentum and observed them under fluorescent microscopy. Green fluorescence was detected in cells that contained black carbon particles in the cytoplasm, demonstrating that the target cells for adenovirus infection at MS were macrophages. We also confirmed by the use of nonspecific esterase staining that the GFP-expressing cells were macrophages (data not shown).
We injected AdNK4 (10 9 PFU, twice) into tumor-free mice and then quantified transgene expression levels in systemic and peritoneal organs and tissues over time using Figure 2 Peritoneal implantation of cancer cells evaluated by GFP imaging. MKN45-GFP (10 6 cells) in 1 ml of PBS were injected i.p. into nude mice. Activated carbon particles (0.5 mg) were injected before cell injection to identify MS as black-stained spots by uptake of carbon particles. The mice were then killed 24 hours after cell injection, and greater omentum, mesentery, gonadal fat, diaphragm, liver, pancreas, and spleen were excised and analyzed for GFP expression by fluorescent microscopy. 
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ELISA for NK4 (Fig 4) . The results showed that on day 2 after final injection of AdNK4, the highest levels of NK4 were detected (9.574.8 ng/g (tissue)) in the omentum, which also has the most abundant numbers of MS; thereafter, expression levels showed a rapid decline but were detectable on day 7. Much less expression was observed in the pancreas, followed by spleen and liver; no systemic expression in the lung or blood was detected.
Influence of tumor-bearing on Ad vector-mediated transgene expression at MS
We demonstrated that Ad particles, as well as cancer cells, selectively accumulated to MS when they were injected i.p. into tumor-free mice. We investigated how cancer cell implantation to MS influences Ad vector-mediated transgene expression. On day 7 after injection of MKN45 cells, when MS had been infiltrated and replaced by cancer cells, we injected AdGFP twice into tumorbearing mice. Compared with tumor-free mice, GFP expression was markedly reduced in tumor-bearing mice, and was only slightly detected at the margin of MS, in macrophages. No GFP expression was detected in the peritoneum other than MS (data not shown). NK4 expression in the omentum was remarkably inhibited in tumor-bearing mice (o0.1 ng/g (tissue)) compared to tumor-free mice (9.574.8 ng/g (tissue)) ( Table 1 ).
Figure 3 Biodistribution of transgene expression by i.p. injection of AdGFP. AdGFP (10 9 PFU) was injected i.p. into tumor-free mice twice on day À2 and day 0 and the mice were killed on days 2, 5, and 7, and GFP expression in the peritoneal cavity was analyzed by fluorescent microscopy. MS were identified as black-stained spots by activated carbon particles. Photographs show the omentum (a,b) and mesentery (c,d) on day 2 under light microscopy (a,c) and fluorescent microscopy (b,d) (original magnification, Â 60). MS macrophages were separated from the omentum of tumor-free mice injected with AdGFP, as described in the Materials and methods, and were observed for GFP expression by fluorescent microscopy. Photographs show MS macrophages from the omentum on day 2 under light microscopy (e) and fluorescent microscopy (f) (original magnification, Â 400).
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Treatment of peritoneal dissemination by i.p. injection of AdNK4
We investigated the suppressive effect of i.p. injection of AdNK4 on peritoneal dissemination of MKN45 cells. In a prophylactic injection model (two injections of Ad vector before cell injection), significant suppression of peritoneal dissemination was observed on day 28 in the AdNK4 group compared to control AdLacZ (tumor number: 19.071.9 versus 33.572.5, Po.01, tumor weight: 0.3270.03 versus 0.8270.15 g, Po.01) (Fig 5a) . In a therapeutic injection model (three injections of Ad vector after cell injection), no suppression of peritoneal dissemination was observed in the AdNK4 group compared to the AdLacZ group (data not shown). By contrast, survival prolongation was observed in the AdNK4 group compared to AdLacZ in the prophylactic model (Po.01) (Fig 5b, left) but not in the therapeutic model (P4.05) (Fig 5b, right) .
Immunohistochemical evaluation
We excised disseminated tumor tissues at 28 days after cell injection and examined microvessel density and apoptosis by immunohistochemical staining. No differences were observed between AdNK4 and control groups in the therapeutic model, or in the prophylactic model in which significant suppression of peritoneal dissemination was observed in AdNK4 (data not shown).
Suppression of peritoneal implantation by Ad vector-mediated NK4 expression
To clarify the mechanism of the suppressive effect of prophylactic AdNK4 on peritoneal dissemination, we quantitatively evaluated the influence of NK4 expression at MS on subsequent implantation of cancer cells to MS by GFP imaging. MKN45-GFP were injected i.p into mice that were pretreated with AdNK4 or AdLacZ twice before cell injection, and cells implanted to the omental MS were quantified by counting GFP-expressing cells. The number of GFP-expressing cells was 1.33 Â 10 6 in AdLacZ but only 0.83 Â 10 6 cells in AdNK4 (Po.05) (Fig 6) .
Discussion
MS are lymphoid tissues in the peritoneum composed of cellular aggregations of mesenchymal cells, mainly macrophages and lymphocytes, surrounding capillary convolutions. Macrophages form clusters near the peritoneal surfaces of MS and are oriented toward the peritoneal cavity for migration; initial lymphatics begin at MS and drain into lymph collectors, which take part in the absorption of various substances from the peritoneal cavity. 5 MS are found mainly in the omentum, with relatively fewer of them appearing in the mesentery and the pelvic floor, and MS are not found in other areas of the peritoneum. 9 Although the exact reason for MSselective implantation of peritoneal free cancer cells is unclear, it probably relates to the function of MS to absorb, or that cancer cells may readily adhere to MS, since MS lack mesothelial cells. 5 In the present study, we found that MS were selective implantation sites of peritoneal free cancer cells and for Ad vector injected i.p. to express the transgene. This was demonstrated by detecting expression of AdGFP at MS that were stained black by uptake of carbon particles. We also demonstrated that MS macrophages were the cells responsible for Ad vector-mediated transgene expression, since green fluorescence and activated carbon particles were simultaneously observed in macrophages dissociated from omental MS.
After i.p. injection of AdGFP or AdNK4 into tumorfree mice, high levels and relatively prolonged transgene expession were detected in the omentum, which has the most abundant MS in the peritoneal cavity. MS-selective transgene expression by Ad vector seems to be favorable and promising for Ad vector-mediated intraperitoneal targeting therapy to prevent peritoneal dissemination. However, the fact that macrophages are the target cells for Ad infection raises concern because they exert vigorous phagocytic activity, which may result in Figure 4 Biodistribution of transgene expression by i.p. injection of AdNK4. AdNK4 (10 9 PFU) was injected i.p. into tumor-free mice twice on day À2 and day 0 and the omentum, liver, pancreas, kidney, lung, and blood were collected from the mice on days 2, 5, and 7. The collected tissues and organs were treated as described in the Materials and methods, and NK4 concentration of each resultant supernatant and blood serum were measured by ELISA. AdNK4 was injected i.p. twice into tumor-free mice or tumorbearing mice that were preinjected with MKN45 cells (10 6 cells) 7 days before Ad injection, and NK4 expression in the peritoneal cavity was evaluated by ELISA. The data were normalized for the weight of each tissue and organ. 
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superoxide dismutase gene could induce high levels of transgene expression in both hepatocytes and Kupffer cells 3 weeks after intravenous injection. 40 The activation status of macrophages and the kind of gene transduced may variably affect transgene expression levels and duration. In our study, the time when macrophages stay at MS after their uptake of Ad particles may affect the duration of transgene expression. These issues require further examination.
We also studied the biodistribution of transgene expression following i.p. injection of Ad vector and demonstrated that in tumor-free mice, Ad-NK4 induced the highest concentrations of NK4 in the omentum, with much lower expression in the pancreas, spleen, and liver. In tumor-bearing mice whose MS were replaced by cancer cells, Ad vector-mediated transgene expression in the omental MS was markedly impaired. MS ability to absorb viral particles may be impaired by infiltrating cancer cells, and Ad infectivity of cancer cells may be lower than for macrophages. In addition, it is reported that Ad vector could transduce mesothelial cells, 41 and i.p. injection of Ad vector into tumor-bearing mice resulted in transgene expression diffusely in peritoneal surfaces.
24,31,41 Saimura et al 24 reported that repeated injection of AdNK4 induced the highest concentrations of NK4 in the liver, followed by the pancreas and spleen in mice bearing peritoneal dissemination of human pancreatic cancer. The biodistribution of Ad vector-mediated transgene expression is variably affected by the viral dose, as well as tumor-free/ tumor-bearing conditions that affect MS function. Intravenous injection of low doses of virus are taken up by Kupffer cells, whereas high doses saturate these cells and are able to transduce hepatocytes. 36 Ad injected i.p. may preferentially transduce MS macrophages in tumor-free mice; when MS macrophages are saturated with high doses of Ad or replaced by cancer cells, then Ad may transduce mesothelial cells via direct contact with peritoneal surfaces. Systemic blood circulation or lymphatics, which originate from MS, may play a role in transgene expression in intraperitoneal organs. In the present study, transgene expression was not detected in the peritoneal surfaces of tumor-bearing mice by i.p. injection of AdGFP, whereas, as was the same with previous studies, 25, 31 it was seen diffusely by i.p. injection of AdLacZ (data not shown). The difference may depend on the expression sensitivity of the gene to be transduced.
We investigated whether i.p. injection of AdNK4 could suppress peritoneal dissemination induced by human gastric cancer MKN45 cells, which show HGF/c-Metdependent enhancement of their motility in vitro, and selective implantation to MS in vivo. NK4 shows potent antitumor activities by suppressing in vivo invasion and metastasis of cancer cells via its actions as an HGF antagonist and an angiogenesis inhibitor. [21] [22] [23] [24] 26 AdNK4 by prophylactic injection induced suppression of peritoneal dissemination and subsequent prolongation of survival, whereas it did not induce substantial antitumor effects as a therapeutic injection. This strongly suggests that MS-selectivity and high levels of NK4 expression may play a critical role in the suppression of MKN45-induced peritoneal dissemination.
We could not find any histologic evidence of angiogenesis inhibition by NK4 in the disseminated tumor nodules formed at MS. However, we confirmed that injection of AdNK4 into subcutaneous tumor of MKN45 induced significant angiogenesis inhibition (data not shown). The difference in the sites of tumor growth may strongly affect the antitumor effects by NK4. MS contain an abundant blood supply with potent angiogenic activity. 42 Therefore, NK4-induced angiogenesis inhibition may have been masked by the potent angiogenic activity of MS, which may also explain the insufficient antitumor effects of therapeutic injection. Our result that as early as 24 hours after cell injection, NK4 expressed at MS suppressed the implantation of peritoneal free cancer cells to MS, strongly suggests the involvement of mechanisms other than angiogenesis inhibition by NK4. Early phases of peritoneal implantation before tumor formation, consisted of adhesion and invasion of cancer cells, are considered to be independent of angiogenesis, since angiogenesis is required for tumor growth larger than 2 mm, 43 whereas those of a smaller size are supported by the diffusion of oxygen and nutrients from blood capillaries. 44 NK4 may have suppressed peritoneal implantation by inhibiting adhesion and/or invasion of cancer cells presumably via an HGF/c-Met pathway. Further studies will be required to clarify the mechanisms underlying the suppression of peritoneal implantation by NK4.
In the treatment of peritoneal dissemination, the target cell population would be the cancer cells rather than MS macrophages, and high doses of Ad vector may have therapeutic effects, by allowing transduction of cancer cells (disseminated tumor) and mesothelial cells (peritoneal Figure 6 Suppression of peritoneal implantation by Ad vectormediated NK4 expression at MS. MKN45-GFP cells (5 Â 10 6 cells) were injected i.p. on day 0 into mice that were preinjected with AdNK4 or AdLacZ (10 9 PFU) twice on day À2 and day 0. On day 1, mice were killed and GFP-expressing cells were counted under fluorescent microscopy. Each value represents the mean7SE (*Po.05).
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H Fujiwara et al surfaces). 24, 31 However, therapeutic injection of Ad vector may fail to suppress the established peritoneal dissemination because of the biological aggressiveness even if high levels of transgene expression had been induced. Our strategy is focusing on MS-selective infectivity of Ad vector; Ad vector injected i.p. preferentially transduce MS macrophages, and low doses of Ad vector induce high levels of transgene expression at MS that can suppress peritoneal implantation of cancer cells. MS-selective infectivity of Ad vector may be feasible as early gene therapy to prevent peritoneal dissemination of gastric cancer.
Materials and methods
Cells
Human gastric cancer cell line, MKN45 (poorly differentiated adenocarcinoma), was obtained from the Riken Cell Bank (Tsukuba, Japan). MKN45 cells were maintained in RPMI 1640 supplemented with 4 mM Lglutamine and NaHCO 3 (Nacalai Tesque, Kyoto, Japan), 100 IU/ml penicillin, and 100 mg/ml streptomycin (Sigma, St Louis, MO), 50 mM 2-mercaptoethanol, and 10% heatinactivated fetal bovine serum (FBS; JRH Bioscience, Lenexa, KS).
Animals
BALB/c female nu/nu mice, aged 8-10 weeks old, were purchased from CLEA Japan (Tokyo, Japan) and housed under specific pathogen-free conditions. The investigation protocols were approved by the Ethical Committee of Kyoto Prefectural University of Medicine.
Ad vectors
The replication-deficient Ad vectors used in this study are based on human Ad5 genome with E1 and E3 deletions. The AdCAG-EGFP (AdGFP) vector that expresses enhanced green fluorescence protein under the control of the CAG early promoter/enhancer was kindly provided by Dr Nishioka (Department of Internal Medicine, Tokushima University, Tokushima, Japan). The AdCMV-NK4 (AdNK4) vector expresses human NK4 (corresponding to 32Glu to 478Val of HGF a-chain) under the control of the cytomegalovirus early promoter/ enhancer. All vectors were amplified in human embryonic kidney 293 cells (Takara, Otsu, Japan). Viral particle concentration (expressed as plaque-forming units (PFU)/ ml) was determined by a plaque formation assay using 293 cells. As a control vector, we used AdCMV-LacZ (AdLacZ), which expresses LacZ under the control of the cytomegalovirus early promoter/enhancer. There was no detectable replication-competent adenovirus or E1 þ virus in the preparation.
Cell proliferation, invasion, and migration assays Subconfluent MKN45 cells were infected with AdNK4 at 50 multiplicity of infection (moi) for 1 hour and incubated in culture media for 1 day. The cells were used as NK4 expressing cells (MKN45-AdNK4) in the following in vitro assays. MKN45 cells infected with AdLacZ were used as control cells (MKN45-AdLacZ). For cell proliferation, the cells in RPMI 1640 with 10% FBS were plated at 2.5 Â 10 3 cells/well onto 24-well tissue culture plates and cultured for 24 hours. The culture media were replaced with fresh RPMI 1640 with 5% FBS, and the cells were cultured in the absence or presence of 10 ng/ml HGF. After 5 days, the cells were dispersed with trypsin/ EDTA and counted. For NK4 production, MKN45-AdNK4 and MKN45-AdLacZ were plated at 10 5 cells/ well onto six-well tissue culture plates and cultured for 48 hours, and the supernatants were measured by human HGF ELISA (Institute of Immunology, Tokyo, Japan). Invasion and migration of MKN45 cells were measured using a 24-well Matrigel invasion chamber (Becton Dickinson, Bedford, MA) and a Transwell chamber (Corning, Cambridge, MA) equipped with a filter membrane with 8 mm pores. The cells suspended in RPMI 1640 with 2% FBS were added to the inner cup of a chamber at a density of 10 5 cells/well. HGF (10 ng/ml) was added to the medium of the outer cup. After 24 hours of culture, cells that invaded or migrated to the opposite side of the membrane were counted after they had been stained with hematoxylin. The invasion and migration assays were performed independently three times, and similar results were obtained in each experiment.
Preparation of cancer cells stably expressing GFP
GFP expression plasmid, pcDNA3/EGFP, is a pcDNA3-derived plasmid containing the GFP sequence under control of the CAG promoter/enhancer. MKN45 cells were transfected with pcDNA3/EGFP by electroporation. Neomycin-resistant cells were selected in 800 mg/ml G418 (GibcoBRL, Grand Island, NY) for 14 days starting at 3 days after transfection. Selected colonies were picked up and examined for GFP expression by fluorescent microscopy. The cells expressing the highest levels of GFP were used as MKN45-GFP in this study.
Assay for MS-selective implantation of cancer cells by GFP imaging
MKN45-GFP (10 6 cells) in 1 ml of PBS were injected i.p. into nude mice. Activated carbon particles 0.5 mg (Nacalai Tesque) were injected before cell injection to identify MS as black-stained spots by the uptake of carbon particles. The mice were then killed 24 hours after cell injection, and the greater omentum, mesentery, gonadal fat, diaphragm, liver, pancreas, and spleen were excised and analyzed for GFP expression by fluorescent microscopy.
Assays for transgene distribution after i.p. injection of Ad vector
AdGFP (10 9 PFU) was injected i.p. into mice twice on day À2 and day 0. The mice were then killed on days 2, 5, and 7, and fresh peritoneal tissues and organs were analyzed NK4 suppresses peritoneal cancer dissemination H Fujiwara et al by fluorescent microscopy. Activated carbon particles were injected before adenovirus injection. To identify cells responsible for Ad infection, the cell suspension was prepared from the omentum according to the method described previously with slight modification. 45 Briefly, the omentum was minced into small tissue fragments and incubated in RPMI 1640 supplemented with 1 mg/ml Collagenase S-1 (250 to 300 units/mg; Nitta Gelatin, Osaka, Japan) and 0.1 mg/ml DNase 1 type IV (3000 units/mg; Sigma) for 30 minutes at 371C on a rock/roller bank, then filtered through a 70 mm cell strainer (Becton Dickinson), washed in RPMI 1640, and kept on ice. The omental macrophages were separated from these collected cell suspensions by plastic dish adhesion for 2 hours. Dish-adherent cells (macrophages) and nonadherent cells were observed for GFP expression by fluorescent microscopy.
To measure NK4 expression in the whole body, AdNK4 (10 9 PFU) was injected i.p. into mice twice as described above, and the omentum, liver, pancreas, kidney, lung, and blood were collected from the mice on days 2, 5, and 7. The collected tissues and organs were homogenized with lysis buffer composed of 10 mM TrisHCl (pH 7.5), 2 M NaCl, 1 mM PMSF, 1 mM EDTA, and 0.01% Tween 80, and the homogenates were centrifuged at 105,000g for 1 hour. The NK4 concentration of each resultant supernatant and blood serum was measured by human HGF ELISA (Institute of Immunology). The data were normalized for the weight of each tissue and organ.
To evaluate the influence of tumor-bearing on Ad vector-mediated transgene expression in the peritoneal cavity, adenovirus vector (AdGFP, AdNK4) was injected i.p. twice into mice that were preinjected with MKN45 cells (10 6 cells) 7 days before Ad injection, and transgene expression was assayed as described above.
Treatment of peritoneal dissemination by i.p. injection of AdNK4
MKN45 (10 6 cells) in 1 ml of PBS were injected i.p. into mice on day 0. AdNK4 or AdLacZ (10 9 PFU) was injected i.p. twice before cell injection (on day À2 and day 0) in the prophylactic injection model, and 3 times after cell injection (on days 3, 8, and 13) in the therapeutic injection model. The mice were then killed on day 28, and the number and weight of disseminated tumor nodules were measured (n ¼ 5 for each group). Survival was evaluated by the Kaplan-Meier method and compared by the log-rank test between AdNK4 and AdLacZ groups (n ¼ 10 for each).
Immunohistochemical studies
Angiogenesis in disseminated tumor tissues was examined by sectioning 70% ethanol-fixed tissues and reacting with rat anti-mouse CD31/PECAM-1 antibody (PharMingen, San Diego, CA), and counterstaining with hematoxylin. 22 The microvessel density was evaluated by counting CD31 positive vessels under light microscopy at 200-fold magnification. To detect apoptotic cells, 10% formalinfixed tissue sections were analyzed by immunohistochemistry for terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay. The in situ Apoptosis Detection Kit (Takara) was used according to the manufacturer's instructions.
Quantitative assay for MS-selective implantation of cancer cells
To quantify the implantation of MKN45 cells to MS, 5 Â 10 6 MKN45-GFP cells were injected i.p. on day 0 into mice that were pretreated with AdNK4 or AdLacZ (10 9 PFU) twice before cell injection on day À2 and on day 0. On day 1, the omentum was resected, and the cell suspension was prepared by mechanical and enzymatic treatment as described above, and the number of GFPexpressing cells was counted and compared between AdNK4 and AdLacZ groups.
Statistical analyses
Statistical analyses were performed with unpaired Student's t-test (two-tailed) unless mentioned otherwise in the text. Differences were considered to be statistically significant at Po.05.
